Skip to content

CDC Vaccine Panel to Review Nerve Disorder Tied to J&J Shot

Video player cover image
J&J Warning to Add to U.S. Vaccine Hesitancy: Johns Hopkins
Updated on

Covid-19 vaccine safety, including the possible risks from a rare immune-system disorder, will be the focus of an advisory panel meeting scheduled by the U.S. Centers for Disease Control and Prevention on July 22.

The announcement by the CDC comes a day after the fact sheet for Johnson & Johnson’s Covid-19 shot was revised by federal regulators to warn about a “small possible risk” for Guillain-Barré Syndrome, in which the immune system attacks the nerves. The Advisory Committee on Immunization Practices, or ACIP, includes medical and public health experts that advise the agency on vaccine use and safety.